Seeann Solution, a Korean company specializing in personalized medical devices, has secured an investment from CNTTECH. With this funding, the company plans to strengthen its position in both the domestic and international markets for customized medical devices and drive growth in the global personalized medical services sector.

Established in 2019, Seeann Solution has developed and commercialized a range of patient-specific medical devices. It currently supplies surgical guides, which are classified as Class II medical devices, to major university hospitals. The company’s key strength lies in its ability to rapidly respond to clinical needs with swift design and production, while maintaining the high precision of its customized medical devices, which are based on individual patient medical images.
With this investment, Seeann Solution intends to establish a production facility for Class III medical devices and accelerate its global expansion.
Hwa-sung Jeon, CEO of CNTTECH, said, “Seeann Solution has demonstrated its ability to commercialize 3D-printed customized medical devices, showcasing outstanding technology and vision. Through this investment, we aim to accelerate Seeann Solution’s market expansion and continue supporting the growth of innovative startups through the Korea Telecommunications Operators Association (KTOA) Venturium.”
Anna Seo, CEO of Seeann Solution, added, “This investment enables us to move forward with our plan to build a production facility for Class III medical devices, such as metal implants that are inserted into the human body. This facility is crucial infrastructure directly tied to our sales growth, and it will be a key stepping stone for our company’s continued advancement.”
As the operator of KTOA Venturium, CNTTECH supports the growth of innovative startups, and this investment was part of that initiative. Since joining Venturium, Seeann Solution has been driving business growth through various networking and support programs.
MORE FROM THE POST
- CNTTech Invests in Littleone to Boost Global Growth in Infant Healthcare Tech
- PROGEN Raises USD 15.5 million to Develop Biopharmaceutical Drug for Obesity-Diabetes
- Bigbang Ventures Backs AllMade’s Next-Gen In-Vitro Diagnostic Platform
- Prazer Therapeutics Raises USD 19.6M to Advance Targeted Protein Degradation
- The Invention Lab Invests $750K in 5 Bio & Healthcare Startups
- BioHealth
- EN
- Korea
- Korea Telecommunications Operators Association
- Korean startup
- KTOA
- Seeann Solution
- venturium
Leave a Reply